These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7196281)

  • 1. Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen.
    Creagan ET; Fleming TR; Edmonson JH; Ingle JN; Woods JE
    Cancer; 1981 Jun; 47(11):2549-51. PubMed ID: 7196281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer.
    Creagan ET; Woods JE; Schutt AJ; O'Fallon JR
    Cancer; 1983 Dec; 52(11):2007-10. PubMed ID: 6684986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen.
    Bitran JD; Goldman M
    Am J Clin Oncol; 1985 Feb; 8(1):61-4. PubMed ID: 2581437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer.
    Creagan ET; Fleming TR; Edmonson JH; Ingle JN; Woods JE
    Cancer; 1981 Jan; 47(2):240-4. PubMed ID: 7193079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide, tetrahydropyranyl-adriamycin, and cis-platinum in the treatment of head and neck adenocarcinoma.
    Kida A; Furusaka T; Endo S; Iida H; Hosokawa T
    Auris Nasus Larynx; 1989; 16 Suppl 1():S119-23. PubMed ID: 2604611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland.
    Alberts DS; Manning MR; Coulthard SW; Koopmann CF; Herman TS
    Cancer; 1981 Feb; 47(4):645-8. PubMed ID: 7194729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, adriamycin, and 24-hour infusion of cis-diamminedichloroplatinum (II) in the management of patients with advanced head and neck neoplasms.
    Creagan ET; O'Fallon JR; Schutt AJ; Rubin J; Woods JE
    Head Neck Surg; 1984; 6(3):738-43. PubMed ID: 6537949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
    Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for recurrent adeno- and adenoidcystic carcinomas in the head and neck.
    Tsukuda M; Kokatsu T; Ito K; Mochimatsu I; Kubota A; Sawaki S
    J Cancer Res Clin Oncol; 1993; 119(12):756-8. PubMed ID: 8408188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism.
    Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S
    Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
    Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
    Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide, Adriamycin, and platinum chemotherapy in treatment of advanced and recurrent cervical carcinoma.
    Lele SB; Piver MS; Barlow JJ
    Gynecol Oncol; 1983 Aug; 16(1):15-8. PubMed ID: 6688405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
    Presant CA; Ratkin G; Klahr C; Brown C
    Cancer; 1979 Nov; 44(5):1571-5. PubMed ID: 227570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer.
    Creagan ET; O'Fallon JR; Woods JE; Ingle JN; Schutt AJ; Nichols WC
    Cancer; 1983 Jun; 51(11):2020-3. PubMed ID: 6682349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
    Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
    Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternating multiagent chemotherapy for advanced ovarian cancer.
    Hernandez E; Rosenshein NB; Villar J; Dillon MB; Ettinger DS; Order SE
    J Surg Oncol; 1983 Feb; 22(2):87-91. PubMed ID: 6296547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating cisplatinum and VAC ineffective in end stage squamous cell carcinoma of the head and neck.
    Siodlak MZ; Stell PM; Wilson JA; Green JA; Allison RS; Adler D; Squadrelli-Saraceno M
    J Laryngol Otol; 1990 Aug; 104(8):631-3. PubMed ID: 2230560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
    Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
    Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.